林 讓均

Medicine & Life Sciences

1. Adenocarcinoma of Lung 13%
2. Adjuvant Chemotherapy 12%
3. Arachnoid Cysts 17%
4. Astrocytoma 14%
5. Basal Ganglia 13%
6. Brain 23%
7. Brain Neoplasms 28%
8. Chemoradiotherapy 16%
9. Conformal Radiotherapy 19%
10. Craniotomy 14%
11. Decompressive Craniectomy 18%
12. Defensins 17%
13. DNA Repair Enzymes 17%
14. Epidermal Growth Factor 12%
15. ErbB Receptors 26%
16. Esophageal Neoplasms 13%
17. Gastropoda 17%
18. Genome-Wide Association Study 13%
19. Germinoma 18%
20. Glioblastoma 91%
21. Glioma 14%
22. Hematoma, Subdural, Chronic 18%
23. Hepatocellular Carcinoma 20%
24. Hydrocephalus 16%
25. Image-Guided Radiotherapy 17%
26. Intensity-Modulated Radiotherapy 100%
27. Intercellular Adhesion Molecule-1 13%
28. Intracranial Hemorrhages 14%
29. Lung 12%
30. Methyltransferases 14%
31. Nasopharyngeal Carcinoma 14%
32. Neoplasm Metastasis 16%
33. Neoplasms 43%
34. Neoplastic Stem Cells 33%
35. O-(6)-methylguanine 17%
36. Organs at Risk 17%
37. Radiation 14%
38. Radiation-Induced Neoplasms 19%
39. Radiosurgery 51%
40. Radiotherapy 75%
41. Recombinational DNA Repair 16%
42. Rectal Neoplasms 13%
43. Solitary Fibrous Tumors 18%
44. STAT3 Transcription Factor 15%
45. Survival 20%
46. Survival Rate 12%
47. Taiwan 17%
48. Therapeutics 16%
49. Thorax 12%
50. Ventriculoperitoneal Shunt 16%